| |
| |
|
| Insider
Information: |
Coughlin Christopher J |
| Relationship: |
|
| City: |
New York |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
11 |
|
| Direct
Shares |
342,599 |
|
|
Indirect Shares
|
17,342 |
|
|
| Direct
Value |
$12,307,323 |
|
|
|
Indirect Value
|
$3,201,457 |
|
|
| Total
Shares |
359,941 |
|
|
| Total
Value |
$15,508,780 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
1
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
-1.0
|
0.0
|
| Percentage
Gain/Loss : |
 -5.9%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Interpublic Group of Companies |
IPG |
CFO and COO, Director |
2004-05-18 |
81,842 |
2004-05-18 |
0 |
Premium* |
|
|
Dun & Bradstreet Corp |
DNB |
Director |
2017-03-10 |
16,535 |
2017-03-10 |
800 |
Premium* |
|
|
Johnson Controls International plc |
JCI |
EVP and CFO |
2010-11-26 |
88,558 |
2005-03-07 |
0 |
Premium* |
|
|
Covidien Plc |
COV |
Director |
2015-01-26 |
0 |
2015-01-26 |
0 |
Premium* |
|
|
Plx Pharma Inc |
PLXP |
Director |
2014-03-18 |
109,309 |
|
0 |
Premium* |
|
|
Allergan plc |
AGN |
Director |
2020-05-08 |
0 |
2020-05-08 |
16,542 |
Premium* |
|
|
Alexion Pharmaceuticals Inc |
ALXN |
Director |
2021-07-21 |
0 |
2014-07-22 |
0 |
Premium* |
|
|
Hologic Inc |
HOLX |
Director |
2017-03-08 |
7,633 |
|
0 |
Premium* |
|
|
Prestige Brands Holdings Inc |
PBH |
Director |
2022-08-02 |
13,218 |
2019-07-30 |
0 |
Premium* |
|
|
Centene Corp |
CNC |
Director |
2024-05-14 |
25,504 |
2022-02-07 |
0 |
Premium* |
|
|
Karuna Therapeutics, Inc. |
KRTX |
|
2024-03-18 |
0 |
2023-06-20 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
180 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 4 of 8
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| DNB |
Dun & Bradstreet Corp |
Director |
– • – |
2008-07-01 |
4 |
A |
$86.88 |
$29,972 |
D/D |
345 |
4,160 |
0 |
- |
|
| DNB |
Dun & Bradstreet Corp |
Director |
– • – |
2008-03-03 |
4 |
A |
$86.22 |
$29,918 |
D/D |
347 |
3,789 |
0 |
- |
|
| CNC |
Centene Corp |
Director |
– • – |
2024-03-31 |
4 |
A |
$0.00 |
$0 |
D/D |
389 |
22,588 |
0 |
- |
|
| CNC |
Centene Corp |
Director |
– • – |
2022-09-30 |
4 |
A |
$0.00 |
$0 |
D/D |
406 |
16,707 |
0 |
- |
|
| DNB |
Dun & Bradstreet Corp |
Director |
– • – |
2006-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
410 |
2,361 |
|
- |
|
| COV |
Covidien Plc |
Director |
• • – |
2014-05-21 |
4 |
A |
$0.00 |
$0 |
D/D |
420 |
49,446 |
0 |
- |
|
| DNB |
Dun & Bradstreet Corp |
Director |
– • – |
2006-07-03 |
4 |
A |
$0.00 |
$0 |
D/D |
430 |
2,791 |
|
- |
|
| CNC |
Centene Corp |
Director |
– • – |
2022-06-30 |
4 |
A |
$0.00 |
$0 |
D/D |
436 |
16,301 |
0 |
- |
|
| CNC |
Centene Corp |
Director |
– • – |
2022-03-31 |
4 |
A |
$82.02 |
$36,250 |
D/D |
442 |
1,542 |
0 |
- |
|
| CNC |
Centene Corp |
Director |
– • – |
2022-12-31 |
4 |
A |
$0.00 |
$0 |
D/D |
444 |
17,151 |
0 |
- |
|
| CNC |
Centene Corp |
Director |
– • – |
2023-12-31 |
4 |
A |
$0.00 |
$0 |
D/D |
502 |
22,199 |
0 |
- |
|
| CNC |
Centene Corp |
Director |
– • – |
2023-06-30 |
4 |
A |
$0.00 |
$0 |
D/D |
544 |
21,152 |
0 |
- |
|
| CNC |
Centene Corp |
Director |
– • – |
2023-09-30 |
4 |
A |
$0.00 |
$0 |
D/D |
545 |
21,697 |
0 |
- |
|
| DNB |
Dun & Bradstreet Corp |
Director |
– • – |
2006-08-11 |
4 |
B |
$67.83 |
$40,862 |
I/I |
600 |
600 |
2.1 |
- |
|
| AGN |
Allergan plc |
Director |
– • – |
2017-05-03 |
4 |
D |
$243.76 |
$162,832 |
D/D |
(668) |
3,223 |
0 |
- |
|
| AGN |
Allergan plc |
Director |
– • – |
2014-10-30 |
4 |
A |
$243.21 |
$168,788 |
D/D |
694 |
18,261 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Director |
– • – |
2015-05-06 |
4 |
A |
$0.00 |
$0 |
D/D |
700 |
1,468 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Director |
– • – |
2014-07-22 |
4 |
A |
$0.00 |
$0 |
D/D |
768 |
768 |
0 |
- |
|
| AGN |
Allergan plc |
Director |
– • – |
2015-06-05 |
4 |
A |
$302.30 |
$249,700 |
D/D |
826 |
2,826 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Director |
– • – |
2016-05-11 |
4 |
A |
$0.00 |
$0 |
D/D |
835 |
2,303 |
0 |
- |
|
| DNB |
Dun & Bradstreet Corp |
Director |
– • – |
2005-07-01 |
4 |
A |
$0.00 |
$0 |
D/D |
927 |
1,951 |
|
- |
|
| DNB |
Dun & Bradstreet Corp |
Director |
– • – |
2005-05-03 |
4 |
A |
$0.00 |
$0 |
D/D |
931 |
1,023 |
|
- |
|
| AGN |
Allergan plc |
Director |
– • – |
2019-04-30 |
4 |
D |
$147.00 |
$140,091 |
D/D |
(953) |
15,016 |
0 |
- |
|
| DNB |
Dun & Bradstreet Corp |
Director |
– • – |
2015-05-06 |
4 |
A |
$0.00 |
$0 |
D/D |
954 |
14,941 |
0 |
- |
|
| KRTX |
Karuna Therapeutics, Inc. |
|
– • – |
2023-06-20 |
4 |
A |
$0.00 |
$0 |
D/D |
990 |
990 |
0 |
- |
|
180 Records found
|
|
Page 4 of 8 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
